GC
CHTP

Guggenheim Capital’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Guggenheim Capital’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-394,786
Closed -$2.18M – 3390
2014
Q1 		$2.18M Buy
394,786
+372,072
+1,638% +$1.87M 0.01% 1730
2013
Q4 		$101K Buy
22,714
+126
+0.6% +$426 ﹤0.01% 2981
2013
Q3 		$68K Buy
22,588
+4,385
+24% +$12.6K ﹤0.01% 2908
2013
Q2 		$42K Buy
+18,203
New +$36.8K ﹤0.01% 2926

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Guggenheim Capital's CHTP Position: Q2 2014 in Review

Guggenheim Capital sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 394,786 shares — an estimated $2.18M sold.

Guggenheim Capital first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $2.18M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Guggenheim Capital reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Guggenheim Capital sold 394,786 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $2.18M.
  • Guggenheim Capital first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Guggenheim Capital's CHELSEA THERAPEUTICS INT'L LTD position peaked at $2.18M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Guggenheim Capital's 13F filing for Q2 2014, filed 14 Aug 2014.